{"id":182057,"date":"2022-09-12T05:30:29","date_gmt":"2022-09-12T05:30:29","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=182057"},"modified":"2022-09-12T05:30:29","modified_gmt":"2022-09-12T05:30:29","slug":"drug-induced-systemic-lupus-erythematosus","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/","title":{"rendered":"Drug induced systemic lupus erythematosus"},"content":{"rendered":"<p>A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold DNA, are common. Some patients develop antinuclear antibodies but do not develop lupus-like symptoms. The lupus-like syndrome usually disappears when the drug causing it is discontinued.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-182057","post","type-post","status-publish","format-standard","hentry","category-d"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Drug induced systemic lupus erythematosus - Definition of Drug induced systemic lupus erythematosus<\/title>\n<meta name=\"description\" content=\"A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold DNA, are common. Some patients develop antinuclear antibodies but do not develop lupus-like symptoms. The lupus-like syndrome usually disappears when the drug causing it is discontinued.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug induced systemic lupus erythematosus - Definition of Drug induced systemic lupus erythematosus\" \/>\n<meta property=\"og:description\" content=\"A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold DNA, are common. Some patients develop antinuclear antibodies but do not develop lupus-like symptoms. The lupus-like syndrome usually disappears when the drug causing it is discontinued.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-12T05:30:29+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/\",\"name\":\"Drug induced systemic lupus erythematosus - Definition of Drug induced systemic lupus erythematosus\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-09-12T05:30:29+00:00\",\"dateModified\":\"2022-09-12T05:30:29+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold DNA, are common. Some patients develop antinuclear antibodies but do not develop lupus-like symptoms. The lupus-like syndrome usually disappears when the drug causing it is discontinued.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug induced systemic lupus erythematosus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug induced systemic lupus erythematosus - Definition of Drug induced systemic lupus erythematosus","description":"A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold DNA, are common. Some patients develop antinuclear antibodies but do not develop lupus-like symptoms. The lupus-like syndrome usually disappears when the drug causing it is discontinued.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/","og_locale":"en_US","og_type":"article","og_title":"Drug induced systemic lupus erythematosus - Definition of Drug induced systemic lupus erythematosus","og_description":"A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold DNA, are common. Some patients develop antinuclear antibodies but do not develop lupus-like symptoms. The lupus-like syndrome usually disappears when the drug causing it is discontinued.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/","og_site_name":"Glossary","article_published_time":"2022-09-12T05:30:29+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/","name":"Drug induced systemic lupus erythematosus - Definition of Drug induced systemic lupus erythematosus","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-09-12T05:30:29+00:00","dateModified":"2022-09-12T05:30:29+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A group of signs and symptoms similar to those of systemic lupus erythematosus, caused by an adverse reaction to drugs, especially procainamide, hydralazine, and isoniazid. Joint inflammation and pain, skin rash, pleurisy, and fever are the most common manifestations; kidney and central nervous system involvement are rare. Antinuclear antibodies, specifically against the histones that fold DNA, are common. Some patients develop antinuclear antibodies but do not develop lupus-like symptoms. The lupus-like syndrome usually disappears when the drug causing it is discontinued.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/drug-induced-systemic-lupus-erythematosus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Drug induced systemic lupus erythematosus"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/182057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=182057"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/182057\/revisions"}],"predecessor-version":[{"id":182058,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/182057\/revisions\/182058"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=182057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=182057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=182057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}